VIVAGEL
LIVE

Serial Number

79197477

Owner

Starpharma Pty Limited

Filing Date

May 2, 2016

Add to watchlist:

No watchlists yet
View on USPTO

VIVAGEL Trademark

Serial Number: 79197477 • Registration: 5477567

VIVAGEL is a trademark filed by Starpharma Pty Limited on May 2, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Starpharma Pty Limited

Baker Building,

Entity Type: 82

Starpharma Pty Ltd (4 trademarks)

PO 2022

Entity Type: 03

Trademark Details

Filing Date

May 2, 2016

Registration Date

May 29, 2018

Published for Opposition

March 13, 2018

Cancellation Date

December 13, 2024

Goods & Services

Pharmaceuticals, pharmaceutical preparations, and pharmaceutical drugs for medical purposes for prevention of viral and bacterial disease, namely, bacterial vaginosis, herpes simplex virus, human papilloma virus, and human immunodeficiency virus (HIV); chemical preparations for pharmaceutical and medical purposes for the prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus and human immunodeficiency virus (HIV); chemical compounds in the nature of antimicrobial or ph balancing or microbial balancing substances all for medical purposes, namely, for treating and preventing vaginal microbial imbalance, vaginal pH imbalance, vaginal odor and discharge, bacterial vaginosis, viral STD, vaginaitis, vaginal thrush, vaginal disease symptom relief including itching, odor, and discharge, for maintaining a healthy balance of vaginal flora and for the reestablishment of the bacterial vaginal flora; polyvalent compounds and dendrimers sold as integral component parts of pharmaceuticals preparations all for medical purposes for the treatment and prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); antimicrobial preparations, namely, microbicidal preparations in the nature of gels, films, solutions, lubricants for vaginal and rectal use for prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); chemical contraceptives, namely, sponges, gels, foams, creams, films, solutions, suspensions and lotions for use in preventing HIV and other sexually transmitted infections; prophylactic preparations for prevention of pregnancy and microbial disease of the reproductive system, namely, chemical contraceptives and antibacterial preparations in the nature of sponges, suppositories, sexual lubricants, gels, foams, creams, films, solutions, suspensions and lotions; pharmaceutical preparations in the nature of vaginal gels and lubricants all for the prevention of pregnancy and sexually transmitted infections and diseases of the human reproductive system

Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices

Filing History

INTERNATIONAL REGISTRATION RENEWED
Apr 9, 2026 RNWL
GENERIC MADRID TRANSACTION SENT TO IB
Feb 4, 2026 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Feb 4, 2026 INNA
GENERIC MADRID TRANSACTION CREATED
Feb 4, 2026 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 13, 2025 INTR
CANCELLED SECTION 71
Dec 13, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 29, 2023 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 7, 2019 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Apr 26, 2019 NREP
CORRECTION UNDER SECTION 7 - PROCESSED
Dec 8, 2018 COC.
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Dec 4, 2018 CORR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 28, 2018 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 30, 2018 TCCA
TEAS SECTION 7 REQUEST RECEIVED
Oct 30, 2018 ES7R
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 6, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 13, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 13, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 29, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
May 29, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Mar 16, 2018 GPNX
PUBLISHED FOR OPPOSITION
Mar 13, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 21, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 21, 2018 OP2R
NOTICE OF PUBLICATION
Feb 21, 2018 NPUB
EXPARTE APPEAL TERMINATED
Feb 6, 2018 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2018 CNSA
EXAMINERS AMENDMENT MAILED
Feb 6, 2018 CNEA
EXAMINER'S AMENDMENT ENTERED
Feb 6, 2018 XAEC
EXAMINERS AMENDMENT -WRITTEN
Feb 6, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2018 CRFA
EX PARTE APPEAL-INSTITUTED
Jan 22, 2018 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 22, 2018 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 22, 2018 EXAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 21, 2018 ERFR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 27, 2017 NREP
FINAL REFUSAL MAILED
Jul 21, 2017 CNFR
FINAL REFUSAL WRITTEN
Jul 20, 2017 CNFR
PARTIAL INVALIDATION PROCESSED BY THE IB
Jul 7, 2017 INNP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2017 CRFA
ASSIGNED TO LIE
Jun 23, 2017 ALIE
REFUSAL PROCESSED BY IB
Jun 9, 2017 RFNT
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 25, 2017 TROA
NEW REPRESENTATIVE AT IB RECEIVED
May 18, 2017 NREP
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 28, 2017 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Feb 10, 2017 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 9, 2017 RFCS
REFUSAL PROCESSED BY MPU
Feb 9, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 9, 2017 RFCR
NON-FINAL ACTION WRITTEN
Feb 8, 2017 CNRT
ASSIGNED TO EXAMINER
Feb 6, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 20, 2016 MAFR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 16, 2016 NREP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 12, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 1, 2016 SDRC